Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study
COGMA
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this research is to look at the effects of computerized cognitive training on anxiety, sleep, mental abilities (cognition), and other aspects of daytime functioning, such as arousal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2020
CompletedStudy Start
First participant enrolled
June 8, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedMarch 15, 2023
March 1, 2023
2.1 years
June 2, 2020
March 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Objective Cognition - Computerized Cognitive Tasks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., processing speed).
Up to 10 weeks
Objective Cognition - Computerized Cognitive Tasks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., attention).
Up to 10 weeks
Objective Cognition - Computerized Cognitive Tasks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., executive function).
Up to 10 weeks
Subjective Cognitive Self-Efficacy. -Cognitive Failures Questionnaire
A 25-item questionnaire. Participants rate from 0 (never) to 4 (very often) frequency of cognitive errors. Higher scores indicate lower cognitive self-efficacy.
Up to 10 weeks
Coronavirus Anxiety Scale
5- item questionnaire that assess anxiety related to the Coronavirus.
Up to 10 weeks
Anxiety - State-Trait Anxiety Inventory
Inventory that asks respondents to rate how true 20 self-descriptive statements (e.g., I feel calm) are on a 4-point scale (1 = not at all, 4 = very much so). Typically, respondents are asked to rate statements according to how they generally feel (trait-anxiety scale) and how they feel in the current moment (state-anxiety scale). Total scores range from 20 to 80, with higher scores indicating greater maladjustment.
Up to 10 weeks
Secondary Outcomes (20)
Game-related experience- Sessions and duration played
Up to 10 weeks
Circadian Rhythm- Morningness-Eveningness Questionnaire
Up to 10 weeks
Subjective Arousal- Global Cognitive Arousal-Perceived Stress Scale
Up to 10 weeks
Subjective Arousal- Pre-sleep Arousal Scale
Up to 10 weeks
Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale Subjective Arousal- Arousal Predisposition Scale
Up to 10 weeks
- +15 more secondary outcomes
Study Arms (2)
Cognitive Training
EXPERIMENTAL8 week computerized cognitive training
Trivia Training
ACTIVE COMPARATOR8 week computerized trivia training
Interventions
Participants (n=15) will complete computerized cognitive training games and activities online 3 times/week for 8 weeks.
Participants (n=15) will receive computerized trivia questions to answer and submit 3 times/week for 8 weeks.
Eligibility Criteria
You may qualify if:
- yrs of age
- no neurological or psychiatric illness, dementia, or loss of consciousness \> 5 mins
- nongamers (i.e., report \<1 hour of video/cognitive training games/week over last 2 yrs)
- proficient in English (reading and writing)
- computer meets technology requirements (i.e. Windows: Windows 7 or above using Internet Explorer 11 or Edge, Mozilla Firefox 41 and above, Google Chrome 48 and above; Mac OS: Mac OS X v10.8 and above using Safari 10 and above, Mozilla Firefox 42 and above, Google Chrome 48 and above; Android App: Android 6 or higher version; iOS App: iOS 10 or higher version
- meet clinical dx criteria for Generalized Anxiety Disorder.
You may not qualify if:
- unable to provide informed consent
- unable to undergo randomization
- Telephone Interview for Cognitive Status-modified (TICS) score \<33, 2)
- other sleep disorder (i.e., sleep apnea, Periodic Limb Movement Disorder-PLMD, narcolepsy, REM Sleep Behavior Disorder)
- severe untreated psychiatric comorbidity that renders randomization unethical
- psychotropic, anxiolytic medications or other medications(e.g., beta-blockers) that alter mood or sleep
- uncorrected visual/auditory impairments
- participation in nonpharmacological treatment for sleep/fatigue/mood outside the current study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri
Columbia, Missouri, 65201, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ashley Curtis, PhD
University of Missouri- School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 2, 2020
First Posted
June 9, 2020
Study Start
June 8, 2020
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
March 15, 2023
Record last verified: 2023-03